查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1908208

循環性腫瘤細胞市場規模、佔有率和趨勢分析報告：按應用、檢體、產品、技術、最終用途、地區和細分市場預測（2026-2033 年）

Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application, By Specimen, By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

循環性腫瘤細胞市場概覽

2025年全球循環性腫瘤細胞（CTC）市場規模估計為140.4億美元，預計2033年將達到389.5億美元。

這主要歸功於循環性腫瘤細胞（CTC）的非侵入性和許多優勢，預計從2026年到2033年，CTC市場將以13.92%的複合年成長率成長。此外，晶片技術的進步也是推動市場成長的關鍵因素。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章循環性腫瘤細胞市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關及輔助市場展望
  • 市場動態
  • 循環性腫瘤細胞市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章循環性腫瘤細胞市場：依技術、估計和趨勢分析

  • 依技術分析全球循環性腫瘤細胞市場的變化
  • 全球循環性腫瘤細胞市場規模及趨勢分析（依技術分類，2021-2033 年）
  • 以下產品的市場規模、預測與趨勢分析（2021-2033）：
    • CTC檢測和富集方法
    • 直接CTC檢測方法
    • CTC分析

第5章循環性腫瘤細胞市場：按應用分類的估計與趨勢分析

  • 依應用領域分析全球循環性腫瘤細胞市場的變化
  • 全球循環性腫瘤細胞市場規模及趨勢分析（按應用領域分類，2021-2033 年）
  • 以下產品的市場規模、預測與趨勢分析（2021-2033）：
    • 臨床
    • 研究

第6章循環性腫瘤細胞市場：產品、估算與趨勢分析

  • 按產品分類的全球循環性腫瘤細胞市場變化分析
  • 全球循環性腫瘤細胞市場規模及趨勢分析（依產品分類，2021-2033 年）
  • 以下產品的市場規模、預測與趨勢分析（2021-2033）：
    • 試劑盒和試劑
    • 採血管
    • 設備或系統

第7章循環性腫瘤細胞市場：檢體類型、估計與趨勢分析

  • 全球循環性腫瘤細胞市場檢體變異性分析
  • 全球循環性腫瘤細胞市場規模及趨勢分析（依檢體，2021-2033 年）
  • 以下產品的市場規模、預測與趨勢分析（2021-2033）：
    • 血
    • 骨髓
    • 其他體液

第8章循環性腫瘤細胞市場：依最終用途分類的估算與趨勢分析

  • 全球循環性腫瘤細胞市場按最終用途分類的差異分析
  • 全球循環性腫瘤細胞市場規模及趨勢分析（依最終用途分類，2021-2033年）
  • 以下產品的市場規模、預測與趨勢分析（2021-2033）：
    • 研究和學術機構
    • 醫院和診所
    • 診斷中心

第9章循環性腫瘤細胞市場：區域分析、預測與趨勢

  • 區域市場佔有率分析（2025 年和 2033 年）
  • 區域市場概覽
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 主要企業地位分析（截至2025年）
  • 主要企業簡介
    • QIAGEN
    • Bio-Techne Corp.
    • Precision Medicine Group, LLC.
    • Bio-Rad Laboratories, Inc.
    • Natera, Inc.
    • Illumina, Inc.
    • Cell Microsystems
    • Greiner Bio One International GmbH
    • Ikonisys Inc.
    • Miltenyi BIoTec
Product Code: 978-1-68038-287-7

Circulating Tumor Cells Market Summary

The global circulating tumor cells market size was estimated at USD 14.04 billion in 2025 and is projected to reach USD 38.95 billion by 2033, expanding at a CAGR of 13.92% from 2026 to 2033, owing to the non-invasiveness and advantages offered by circulating tumor cells (CTC), it is considered a promising tool in cancer diagnosis. In addition, technological advancements in chip technology are another key factor driving market growth.

Global Circulating Tumor Cells Market Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global circulating tumor cells market on the basis of technology, application, product, specimen, end use, and region.

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Circulating Tumor Cells CTC Detection & Enrichment Methods
    • Immunocapture (Label-based)
    • Positive Selection
    • Negative Selection
    • Size-based Separation (Label-free)Density-based Separation (Label-free)
    • Membrane-based
    • Microfluidic-based
    • Density-based Separation (Label-free)
    • Combined Methods
  • CTC Direct Detection Methods
  • CTC Analysis
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical
    • Risk Assessment
    • Screening and Monitoring
  • Research
    • Cancer Stem Cell & Tumorogenesis Research
    • Drug/Therapy Development
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits & Reagents
  • Blood Collection Tubes
  • Devices or Systems
  • Specimen Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood
  • Bone Marrow
  • Other Body Fluids
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Research and Academic Institutes
  • Hospital and Clinics
  • Diagnostic Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Application
    • 1.2.3. Product
    • 1.2.4. Specimen
    • 1.2.5. End use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Circulating Tumor Cells Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in chip technology
      • 3.2.1.2. Expanding applications of CTCs
      • 3.2.1.3. Growing demand for early and rapid cancer diagnosis
      • 3.2.1.4. Growing incidence of cancer
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Consistency-related challenges in CTC detection and enrichment
      • 3.2.2.2. Higher preference for Point-of-Care (POC) testing and nonavailability of POC adaptable CTC tests
      • 3.2.2.3. Lower applicability of CTCs in rare cancers
  • 3.3. Circulating Tumor Cells Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Circulating Tumor Cells Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Segment Dashboard
  • 4.2. Global Circulating Tumor Cells Market Technology Movement Analysis
  • 4.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.4.1. CTC Detection & Enrichment Methods
      • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.1.2. Immunocapture (Label-based)
        • 4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.1.2.2. Positive Selection
          • 4.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.1.2.3. Negative Selection
          • 4.4.1.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.1.3. Size-based Separation (Label-free)
        • 4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.1.3.2. Membrane-based
          • 4.4.1.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.1.3.3. Microfluidic-based
          • 4.4.1.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.1.4. Density-based Separation (Label-free)
        • 4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.1.5. Combined Methods
        • 4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. CTC Direct Detection Methods
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.2. SERS
        • 4.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.3. Microscopy
        • 4.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.4. Others
        • 4.4.2.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. CTC Analysis
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Circulating Tumor Cells Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Circulating Tumor Cells Market Application Movement Analysis
  • 5.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. Clinical
      • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.1.2. Risk Assessment
        • 5.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.1.3. Screening and Monitoring
        • 5.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Research
      • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.2. Cancer Stem Cell & Tumorogenesis Research
        • 5.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.3. Drug/Therapy Development
        • 5.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Circulating Tumor Cells Market: Product Estimates & Trend Analysis

  • 6.1. Product Segment Dashboard
  • 6.2. Global Circulating Tumor Cells Market Product Movement Analysis
  • 6.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 6.4.1. Kits & reagents
      • 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Blood collection tubes
      • 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. Devices or systems
      • 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Circulating Tumor Cells Market: Specimen Estimates & Trend Analysis

  • 7.1. Specimen Segment Dashboard
  • 7.2. Global Circulating Tumor Cells Market Specimen Movement Analysis
  • 7.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by Specimen, 2021 to 2033 (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 7.4.1. Blood
      • 7.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Bone marrow
      • 7.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Other body fluids
      • 7.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Circulating Tumor Cells Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. Global Circulating Tumor Cells Market End Use Movement Analysis
  • 8.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 8.4.1. Research and academic institutes
      • 8.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.2. Hospital and clinics
      • 8.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.3. Diagnostic centers
      • 8.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Circulating Tumor Cells Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2025 & 2033
  • 9.2. Regional Market Dashboard
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.3.1.5. Target disease prevalence
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.3.2.5. Target disease prevalence
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.3.3.5. Target disease prevalence
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.4.1.5. Target disease prevalence
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.4.2.5. Target disease prevalence
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.4.3.5. Target disease prevalence
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.4.4.5. Target disease prevalence
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.4.5.5. Target disease prevalence
    • 9.4.6. Norway
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.4.6.5. Target disease prevalence
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.4.7.5. Target disease prevalence
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.4.8.5. Target disease prevalence
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.5.1.5. Target disease prevalence
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.5.2.5. Target disease prevalence
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.5.3.5. Target disease prevalence
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.5.4.5. Target disease prevalence
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.5.5.5. Target disease prevalence
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.5.6.5. Target disease prevalence
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.6.1.5. Target disease prevalence
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.6.2.5. Target disease prevalence
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.7.1.5. Target disease prevalence
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.7.2.5. Target disease prevalence
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.7.3.5. Target disease prevalence
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
      • 9.7.4.5. Target disease prevalence

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Key company position analysis, 2025
  • 10.4. Key Company Profiles
    • 10.4.1. QIAGEN
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Bio-Techne Corp.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Precision Medicine Group, LLC.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Bio-Rad Laboratories, Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Natera, Inc.
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Illumina, Inc.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Cell Microsystems
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Greiner Bio One International GmbH
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Ikonisys Inc.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Miltenyi Biotec
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America circulating tumor cells market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 4 North America circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 6 North America circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 7 North America circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 9 U.S. circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S. circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 12 U.S. circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 14 Canada circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 16 Canada circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 17 Canada circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 18 Mexico circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 19 Mexico circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 20 Mexico circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 21 Mexico circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 22 Mexico circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 23 Europe circulating tumor cells market, by region, 2021 - 2033 (USD Million)
  • Table 24 Europe circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 25 Europe circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 26 Europe circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 27 Europe circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 28 Europe circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 29 UK circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 30 UK circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 31 UK circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 32 UK circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 33 UK circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Germany circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 35 Germany circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 36 Germany circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 37 Germany circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 38 Germany circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Italy circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 40 Italy circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 41 Italy circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 42 Italy circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 43 Italy circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 44 France circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 45 France circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 46 France circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 47 France circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 48 France circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Spain circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Spain circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 51 Spain circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 52 Spain circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 53 Spain circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Sweden circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 55 Sweden circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 56 Sweden circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 57 Sweden circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 58 Sweden circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Denmark circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 60 Denmark circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 61 Denmark circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 62 Denmark circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 63 Denmark circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Norway circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 65 Norway circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 66 Norway circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 67 Norway circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 68 Norway circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Asia Pacific circulating tumor cells market, by region, 2021 - 2033 (USD Million)
  • Table 70 Asia Pacific circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 71 Asia Pacific circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 72 Asia Pacific circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 73 Asia Pacific circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 74 Asia Pacific circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 75 China circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 76 China circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 77 China circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 78 China circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 79 China circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 80 Japan circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 81 Japan circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 82 Japan circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 83 Japan circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 84 Japan circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 85 India circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 86 India circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 87 India circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 88 India circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 89 India circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 90 South Korea circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 91 South Korea circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 92 South Korea circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 93 South Korea circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 94 South Korea circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Australia circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 96 Australia circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 97 Australia circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 98 Australia circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 99 Australia circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 100 Thailand circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 101 Thailand circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 102 Thailand circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 103 Thailand circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 104 Thailand circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 105 Latin America circulating tumor cells market, by region, 2021 - 2033 (USD Million)
  • Table 106 Latin America circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 107 Latin America circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 108 Latin America circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 109 Latin America circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 110 Latin America circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 111 Brazil circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 112 Brazil circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 113 Brazill circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 114 Brazil circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 115 Brazil circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 116 Argentina circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 117 Argentina circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 118 Argentina circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 119 Argentina circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 120 Argentina circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 121 Middle East Africa circulating tumor cells market, by region, 2021 - 2033 (USD Million)
  • Table 122 Middle East Africa circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 123 Middle East Africa circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 124 Middle East Africa circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 125 Middle East Africa circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 126 Middle East Africa circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 127 South Africa circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 128 South Africa circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 129 South Africa circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 130 South Africa circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 131 South Africa circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 132 Saudi Arabia circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 133 Saudi Arabia circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 134 Saudi Arabia circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 135 Saudi Arabia circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 136 Saudi Arabia circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 137 UAE circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 138 UAE circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 139 UAE circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 140 UAE circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 141 UAE circulating tumor cells market, by end use, 2021 - 2033 (USD Million)
  • Table 142 Kuwait circulating tumor cells market, by technology, 2021 - 2033 (USD Million)
  • Table 143 Kuwait circulating tumor cells market, by application, 2021 - 2033 (USD Million)
  • Table 144 Kuwait circulating tumor cells market, by product, 2021 - 2033 (USD Million)
  • Table 145 Kuwait circulating tumor cells market, by specimen, 2021 - 2033 (USD Million)
  • Table 146 Kuwait circulating tumor cells market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Circulating tumor cells market: market outlook
  • Fig. 9 Circulating tumor cells competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Circulating tumor cells market driver impact
  • Fig. 15 Circulating tumor cells market restraint impact
  • Fig. 16 Circulating tumor cells market strategic initiatives analysis
  • Fig. 17 Circulating tumor cells market: Technology movement analysis
  • Fig. 18 Circulating tumor cells market: Technology outlook and key takeaways
  • Fig. 19 CTC detection & enrichment methods market estimates and forecast, 2021 - 2033
  • Fig. 20 Immunocapture (label-based) estimates and forecast, 2021 - 2033
  • Fig. 21 Positive selection market estimates and forecast, 2021 - 2033
  • Fig. 22 Negative selection estimates and forecast, 2021 - 2033
  • Fig. 23 Size-based separation (label-free) market estimates and forecast, 2021 - 2033
  • Fig. 24 Membrane-based estimates and forecast, 2021 - 2033
  • Fig. 25 Microfluidic-based estimates and forecast, 2021 - 2033
  • Fig. 26 Density-based Separation (Label-free) estimates and forecast, 2021 - 2033
  • Fig. 27 Combined Methods estimates and forecast, 2021 - 2033
  • Fig. 28 CTC direct detection methods estimate and forecast, 2021 - 2033
  • Fig. 29 SERS estimates and forecast, 2021 - 2033
  • Fig. 30 Microscopy estimates and forecast, 2021 - 2033
  • Fig. 31 Others estimates and forecast, 2021 - 2033
  • Fig. 32 CTC Analysis estimates and forecast, 2021 - 2033
  • Fig. 33 Circulating tumor cells Market: Application movement Analysis
  • Fig. 34 Circulating tumor cells market: Application outlook and key takeaways
  • Fig. 35 Clinical/ Liquid Biopsy market estimates and forecasts, 2021 - 2033
  • Fig. 36 Risk Assessment market estimates and forecasts, 2021 - 2033
  • Fig. 37 Screening and Monitoring market estimates and forecasts, 2021 - 2033
  • Fig. 38 Research market estimates and forecasts, 2021 - 2033
  • Fig. 39 Cancer Stem Cell & Tumorogenesis Research market estimates and forecasts, 2021 - 2033
  • Fig. 40 Drug/Therapy Development market estimates and forecasts, 2021 - 2033
  • Fig. 41 Circulating tumor cells Market: Product movement Analysis
  • Fig. 42 Circulating tumor cells market: Product outlook and key takeaways
  • Fig. 43 Kits & reagents market estimates and forecasts, 2021 - 2033
  • Fig. 44 Blood collection tubes market estimates and forecasts, 2021 - 2033
  • Fig. 45 Devices or Systems market estimates and forecasts, 2021 - 2033
  • Fig. 46 Circulating tumor cells Market: Specimen movement Analysis
  • Fig. 47 Circulating tumor cells market: Specimen outlook and key takeaways
  • Fig. 48 Blood market estimates and forecasts, 2021 - 2033
  • Fig. 49 Bone marrow market estimates and forecasts, 2021 - 2033
  • Fig. 50 Other body fluids market estimates and forecasts, 2021 - 2033
  • Fig. 51 Circulating tumor cells Market: End use movement Analysis
  • Fig. 52 Circulating tumor cells market: End use outlook and key takeaways
  • Fig. 53 Research and academic institutes market estimates and forecasts, 2021 - 2033
  • Fig. 54 Hospital and clinics market estimates and forecasts, 2021 - 2033
  • Fig. 55 Diagnostic centers market estimates and forecasts, 2021 - 2033
  • Fig. 56 Global circulating tumor cells market: Regional movement analysis
  • Fig. 57 Global circulating tumor cells market: Regional outlook and key takeaways
  • Fig. 58 North America, by country
  • Fig. 59 North America
  • Fig. 60 North America market estimates and forecasts, 2021 - 2033
  • Fig. 61 U.S. country dynamics
  • Fig. 62 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 63 Canada country dynamics
  • Fig. 64 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 65 Mexico country dynamics
  • Fig. 66 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 67 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 68 UK country dynamics
  • Fig. 69 UK market estimates and forecasts, 2021 - 2033
  • Fig. 70 Germany country dynamics
  • Fig. 71 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 72 France country dynamics
  • Fig. 73 France market estimates and forecasts, 2021 - 2033
  • Fig. 74 Italy country dynamics
  • Fig. 75 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 76 Spain country dynamics
  • Fig. 77 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 78 Denmark country dynamics
  • Fig. 79 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 80 Sweden country dynamics
  • Fig. 81 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 82 Norway country dynamics
  • Fig. 83 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 84 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 85 China country dynamics
  • Fig. 86 China market estimates and forecasts, 2021 - 2033
  • Fig. 87 Japan country dynamics
  • Fig. 88 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 89 India country dynamics
  • Fig. 90 India market estimates and forecasts, 2021 - 2033
  • Fig. 91 Thailand country dynamics
  • Fig. 92 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 93 South Korea country dynamics
  • Fig. 94 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 95 Australia country dynamics
  • Fig. 96 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 97 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 98 Brazil country dynamics
  • Fig. 99 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 100 Argentina country dynamics
  • Fig. 101 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 102 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 103 South Africa country dynamics
  • Fig. 104 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 105 Saudi Arabia country dynamics
  • Fig. 106 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 107 UAE country dynamics
  • Fig. 108 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 109 Kuwait country dynamics
  • Fig. 110 Kuwait market estimates and forecasts, 2021 - 2033